These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
365 related articles for article (PubMed ID: 31706303)
1. Liraglutide improves lipid metabolism by enhancing cholesterol efflux associated with ABCA1 and ERK1/2 pathway. Wu YR; Shi XY; Ma CY; Zhang Y; Xu RX; Li JJ Cardiovasc Diabetol; 2019 Nov; 18(1):146. PubMed ID: 31706303 [TBL] [Abstract][Full Text] [Related]
2. Liraglutide downregulates hepatic LDL receptor and PCSK9 expression in HepG2 cells and db/db mice through a HNF-1a dependent mechanism. Yang SH; Xu RX; Cui CJ; Wang Y; Du Y; Chen ZG; Yao YH; Ma CY; Zhu CG; Guo YL; Wu NQ; Sun J; Chen BX; Li JJ Cardiovasc Diabetol; 2018 Apr; 17(1):48. PubMed ID: 29618348 [TBL] [Abstract][Full Text] [Related]
3. [Liraglutide protects against nonalcoholic fatty liver disease in ApoE knockout mice with high-fat diet and silenced Acrp30 by increasing AMPK]. Zhao XY; Zhang LL; Suolang QZ; Yang GY; Li L; Li SB; Chen WW Zhonghua Gan Zang Bing Za Zhi; 2014 Nov; 22(11):849-53. PubMed ID: 25531383 [TBL] [Abstract][Full Text] [Related]
4. Role of ATP-binding cassette transporter A1 in suppressing lipid accumulation by glucagon-like peptide-1 agonist in hepatocytes. Lyu J; Imachi H; Fukunaga K; Sato S; Kobayashi T; Dong T; Saheki T; Matsumoto M; Iwama H; Zhang H; Murao K Mol Metab; 2020 Apr; 34():16-26. PubMed ID: 32180556 [TBL] [Abstract][Full Text] [Related]
5. Nucleolin protects macrophages from oxLDL-induced foam cell formation through up-regulating ABCA1 expression. Li Y; Jiang B; Liang P; Tong Z; Liu M; Lv Q; Liu Y; Liu X; Tang Y; Xiao X Biochem Biophys Res Commun; 2017 Apr; 486(2):364-371. PubMed ID: 28315324 [TBL] [Abstract][Full Text] [Related]
6. Heat shock protein 70 accelerates atherosclerosis by downregulating the expression of ABCA1 and ABCG1 through the JNK/Elk-1 pathway. Zhao ZW; Zhang M; Chen LY; Gong D; Xia XD; Yu XH; Wang SQ; Ou X; Dai XY; Zheng XL; Zhang DW; Tang CK Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Aug; 1863(8):806-822. PubMed ID: 29678642 [TBL] [Abstract][Full Text] [Related]
7. Pharmacological efficacy of FGF21 analogue, liraglutide and insulin glargine in treatment of type 2 diabetes. Ye X; Qi J; Yu D; Wu Y; Zhu S; Li S; Wu Q; Ren G; Li D J Diabetes Complications; 2017 Apr; 31(4):726-734. PubMed ID: 28143735 [TBL] [Abstract][Full Text] [Related]
8. Berberine attenuates atherosclerotic lesions and hepatic steatosis in ApoE Ma CY; Shi XY; Wu YR; Zhang Y; Yao YH; Qu HL; Zhang W; Guo YL; Xu RX; Li JJ Ann Transl Med; 2021 Oct; 9(20):1517. PubMed ID: 34790723 [TBL] [Abstract][Full Text] [Related]
9. Agriophyllum oligosaccharides ameliorate hepatic injury in type 2 diabetic db/db mice targeting INS-R/IRS-2/PI3K/AKT/PPAR-γ/Glut4 signal pathway. Bao S; Wu YL; Wang X; Han S; Cho S; Ao W; Nan JX J Ethnopharmacol; 2020 Jul; 257():112863. PubMed ID: 32302715 [TBL] [Abstract][Full Text] [Related]
10. AICAR upregulates ABCA1/ABCG1 expression in the retinal pigment epithelium and reduces Bruch's membrane lipid deposit in ApoE deficient mice. Kim YK; Hong HK; Yoo HS; Park SP; Park KH Exp Eye Res; 2021 Dec; 213():108854. PubMed ID: 34808137 [TBL] [Abstract][Full Text] [Related]
11. Leonurine Prevents Atherosclerosis Via Promoting the Expression of ABCA1 and ABCG1 in a Pparγ/Lxrα Signaling Pathway-Dependent Manner. Jiang T; Ren K; Chen Q; Li H; Yao R; Hu H; Lv YC; Zhao GJ Cell Physiol Biochem; 2017; 43(4):1703-1717. PubMed ID: 29045950 [TBL] [Abstract][Full Text] [Related]
12. Glucagon-Like Peptide-1 Modulates Cholesterol Homeostasis by Suppressing the miR-19b-Induced Downregulation of ABCA1. Yao Y; Li Q; Wang W; Zhang J; Gao P; Xu Y Cell Physiol Biochem; 2018; 50(2):679-693. PubMed ID: 30308521 [TBL] [Abstract][Full Text] [Related]
13. Liraglutide improves hepatic insulin resistance via the canonical Wnt signaling pathway. Qin Y; Chen M; Yang Y; Zhou XR; Shao SY; Wang DW; Yuan G Mol Med Rep; 2018 May; 17(5):7372-7380. PubMed ID: 29568881 [TBL] [Abstract][Full Text] [Related]
14. Lipid abnormalities in alpha/beta2-syntrophin null mice are independent from ABCA1. Hebel T; Eisinger K; Neumeier M; Rein-Fischboeck L; Pohl R; Meier EM; Boettcher A; Froehner SC; Adams ME; Liebisch G; Krautbauer S; Buechler C Biochim Biophys Acta; 2015 May; 1851(5):527-36. PubMed ID: 25625330 [TBL] [Abstract][Full Text] [Related]
15. Celastrus Orbiculatus Thunb. Reduces Lipid Accumulation by Promoting Reverse Cholesterol Transport in Hyperlipidemic Mice. Zhang Y; Si Y; Zhai L; Guo S; Zhao J; Sang H; Pang X; Zhang X; Chen A; Qin S Lipids; 2016 Jun; 51(6):677-92. PubMed ID: 27017606 [TBL] [Abstract][Full Text] [Related]
16. Increased expression of ATP-binding cassette transporter A1 (ABCA1) as a possible mechanism for the protective effect of cilostazol against hepatic steatosis. Jeon BH; Lee YH; Yun MR; Kim SH; Lee BW; Kang ES; Lee HC; Cha BS Metabolism; 2015 Nov; 64(11):1444-53. PubMed ID: 26362727 [TBL] [Abstract][Full Text] [Related]
17. Role of ABCA1 on membrane cholesterol content, insulin-dependent Akt phosphorylation and glucose uptake in adult skeletal muscle fibers from mice. Sánchez-Aguilera P; Diaz-Vegas A; Campos C; Quinteros-Waltemath O; Cerda-Kohler H; Barrientos G; Contreras-Ferrat A; Llanos P Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Dec; 1863(12):1469-1477. PubMed ID: 30254016 [TBL] [Abstract][Full Text] [Related]
18. Tanshinone IIA Promotes Macrophage Cholesterol Efflux and Attenuates Atherosclerosis of apoE-/- Mice by Omentin-1/ABCA1 Pathway. Tan YL; Ou HX; Zhang M; Gong D; Zhao ZW; Chen LY; Xia XD; Mo ZC; Tang CK Curr Pharm Biotechnol; 2019; 20(5):422-432. PubMed ID: 30947667 [TBL] [Abstract][Full Text] [Related]
19. Fargesin alleviates atherosclerosis by promoting reverse cholesterol transport and reducing inflammatory response. Wang G; Gao JH; He LH; Yu XH; Zhao ZW; Zou J; Wen FJ; Zhou L; Wan XJ; Tang CK Biochim Biophys Acta Mol Cell Biol Lipids; 2020 May; 1865(5):158633. PubMed ID: 31988050 [TBL] [Abstract][Full Text] [Related]
20. SIRT1 activator E1231 protects from experimental atherosclerosis and lowers plasma cholesterol and triglycerides by enhancing ABCA1 expression. Feng T; Liu P; Wang X; Luo J; Zuo X; Jiang X; Liu C; Li Y; Li N; Chen M; Zhu N; Han X; Liu C; Xu Y; Si S Atherosclerosis; 2018 Jul; 274():172-181. PubMed ID: 29787963 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]